The absence of SIP1 mutations in HCC cell lines prompted us to explore the role of DNA methylation and/or histone deacetylation as mechanisms that operate on SIP1 downregulation in HCC. The gene discussed is ZEB2; the disease is hepatocellular carcinoma.